candesartan cilexetil has been researched along with endothelin-1 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akehi, N; Hori, M; Kondo, H; Kuzuya, T; Mano, T; Masuyama, T; Miwa, T; Nishikawa, N; Sakata, Y; Yamamoto, K | 1 |
| Hara, K; Kobayashi, N; Matsuoka, H; Mori, Y; Nakano, S; Tsubokou, Y | 1 |
| Dohi, K; Isaka, N; Ito, M; Kitamura, T; Nakano, T; Okinaka, T; Onishi, K | 1 |
| Goto, Y; Hayakawa, N; Imamura, S; Ishiwata, Y; Itoh, M; Itoh, Y; Kakizawa, H; Kato, T; Matsumoto, T; Nagasaka, A; Oda, N; Ono, Y; Senda, T; Yamamoto, K | 1 |
| Hara, Y; Imaki, T; Naruse, M; Takagi, S; Takano, K; Tanabe, A | 1 |
5 other study(ies) available for candesartan cilexetil and endothelin-1
| Article | Year |
|---|---|
Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Topics: Angiotensin Receptor Antagonists; Animals; Aspartic Acid Endopeptidases; Benzimidazoles; Biphenyl Compounds; Diastole; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Endothelins; Heart Failure; Heart Ventricles; Hypertension; Male; Metalloendopeptidases; Peptidyl-Dipeptidase A; Protein Precursors; Pyrimidines; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Endothelin A; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Sulfonamides; Tetrazoles | 2000 |
Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Body Weight; Collagen; Endothelin Receptor Antagonists; Endothelin-1; Heart Ventricles; Hemodynamics; Hypertension; Male; Organ Size; Platelet-Derived Growth Factor; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Endothelin A; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Ventricular Remodeling | 2001 |
Functional role of endogenous endothelin-1 in congestive heart failure treated with angiotensin II receptor antagonist.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Endothelin-1; Heart Failure; Hemodynamics; Male; Random Allocation; Receptors, Angiotensin; Tetrazoles; Ventricular Function, Left | 2001 |
Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
Topics: Albuminuria; Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Enalapril; Endothelin-1; Kidney; Male; Rats; Rats, Wistar; Streptozocin; Tetrazoles; Vascular Endothelial Growth Factor A | 2004 |
Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Endothelin-1; Gene Expression Regulation; Hypertension; Injections, Subcutaneous; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Spironolactone; Tetrazoles; Time Factors | 2004 |